gavin
Topics Engaged In
-
- Topic
- Voices
- Last Post
-
- The landscape of predictive biomarkers for ATR inhibition in Chinese solid-tumor
- 1
- 4 years, 3 months ago
- Pan-cancer analysis of FGFR1-3 genomic alterations to reveal a complex molecular
- 1
- 4 years, 3 months ago
- IDH1 mutation detection in plasma circulating tumor DNA (ctDNA) and association
- 1
- 4 years, 3 months ago
- Phase II study of pembrolizumab plus olaparib in the treatment of patients with
- 1
- 4 years, 3 months ago
- The prevalence of KRASG12C mutations utilizing circulating tumor DNA (ctDNA) in
- 1
- 4 years, 3 months ago
- Combination immunotherapy with ipilimumab and nivolumab in patients with advance
- 1
- 4 years, 3 months ago
- Correlation of pathogenic POLE mutations with clinical benefit to immune checkpo
- 1
- 4 years, 3 months ago
- Phase II basket trial of olaparib and durvalumab in patients (pts) with isocitra
- 1
- 4 years, 3 months ago
- Efficacy of telotristat ethyl: A peripheral tryptophan hydroxylase inhibitor tha
- 1
- 4 years, 3 months ago
- The natural history of fibroblast growth factor receptor (FGFR)-altered cholangi
- 1
- 4 years, 3 months ago
- Perioperative MVT-5873, a fully human monoclonal antibody against a CA 19-9 epit
- 1
- 4 years, 3 months ago
- Final results from the phase I study expansion cohort of the selective FGFR inhi
- 1
- 4 years, 3 months ago